+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

S

Actively Recruiting

The trial investigates the effects of neoadjuvant radiotherapy NART on acute post-surgical complications following mastectomy and immediate breast reconstruction in women with breast cancer. Researchers aim to determine whether NART can reduce complications compared to the standard postmastectomy radiotherapy PMRT, which is associated with higher complication rates and poorer cosmetic outcomes. This pilot study focuses on assessing the safety of NART in this setting, with future studies planned to evaluate long-term quality of life and cancer outcomes if complication rates are acceptable. Participants will receive neoadjuvant radiotherapy consisting of 15 sessions of 2.67 Gy each, delivered five times per week, starting 6 to 8 weeks after the last chemotherapy treatment if applicable. Approximately 2 to 6 weeks after completing radiotherapy, patients will undergo mastectomy with immediate breast reconstruction using either a silicone implant or autologous tissue, commonly the Deep Inferior Epigastric Perforator DIEP flap. This single-arm interventional pilot study will include twenty female breast cancer patients who require mastectomy and radiotherapy and desire immediate reconstruction. During the study, participants will be monitored for acute post-surgical complications up to three months after their latest reconstructive surgery. Researchers will assess treatment-related adverse events, patient-reported satisfaction with breasts and well-being using the BREAST-Q questionnaire, and cosmetic results as rated by physicians. Additional evaluations include the timing of any adjuvant therapy and pathological response in the mastectomy specimen. Participants will also complete questionnaires about cosmetic outcomes and quality of life, requiring about 15 to 30 minutes each. The total study duration includes surgery, radiotherapy, and follow-up assessments within a few months.

Age: 18Years - 75YearsFEMALEPhase Not Applicable
1 location
H

Actively Recruiting

This research aims to evaluate the effectiveness and treatment processes of the Hold Me TightLet Me Go HmTLmG course designed to improve parent-adolescent relationships. The study focuses on families with adolescents aged 12 to 18 who experience problems worsened by stressful parent-adolescent interactions. The trial applies self-reports, audio observations, and interviews to assess changes in relationship satisfaction and negative interaction patterns. The intervention includes a group course for parents from 4 to 6 families, consisting of four group sessions featuring psycho-education and skills training. Additionally, each family participates in three individual sessions one with the adolescent, one with the parents, and one with both together. The course covers topics such as adolescent needs, emotional validation, and communication skills, with exercises and role plays to practice these skills. Participants undergo a screening intake session, followed by assessments at multiple points before treatment, during treatment, and at follow-up. Measurements include questionnaires for parents and adolescents, interviews, and audio recordings of sessions. The timeline includes a waiting period of about five weeks, a treatment phase of six weeks, and a follow-up period of eight weeks. Researchers will measure changes in relationship satisfaction, negative patterns, adolescents psychological needs, support seeking, quality of life, and emotional responsiveness.

Age: 12Years - 18YearsAll Genders
5 locations
C

Actively Recruiting

Healthy Volunteer

Researchers are evaluating treatment approaches for cryptoglandular anal fistulas, a painful and recurring condition that can cause discharge and require a prolonged treatment course. The trial compares two common strategies for patients with a single-tract mid-high or high cryptoglandular anal fistula one involving loose seton placement before surgery and one with direct sphincter-preserving surgery without prior seton. The study aims to determine if skipping the seton placement is not worse in terms of fistula healing 26 weeks after surgery. Participants are randomly assigned to either receive a loose seton placed for about 8 weeks followed by sphincter-preserving surgery, or to have the surgery directly without seton placement. The specific surgical technique is chosen by the surgeon based on local practice and fistula anatomy and may include methods like advancement flap, ligation of the intersphincteric fistula tract, or laser ablation. The study uses a randomized controlled design across multiple centers to compare these two approaches. During the study, participants complete questionnaires measuring quality of life, pain, continence, and anorectal symptoms at several time points up to 12 months. Clinical outcomes like healing, complications, and re-interventions are recorded. The main outcome is successful fistula closure 26 weeks after surgery, confirmed by physical exam and imaging if needed. The study also assesses return to work, healthcare use, and societal costs. Data are securely collected and analyzed to determine if omitting seton placement can reduce treatment burden and costs while maintaining patient outcomes.

Age: 18Years +All GendersPhase Not Applicable
2 locations
L

Actively Recruiting

Researchers are studying women with node-positive breast cancer who receive neoadjuvant systemic therapy NST, which includes chemotherapy with or without immunotherapy. The study aims to understand the safety and quality of life effects of using less invasive methods compared to more invasive axillary staging and treatment after NST. This is important because patients whose lymph nodes show no remaining cancer after NST may not benefit from extensive lymph node removal, but more evidence is needed about the safety and impact of less invasive approaches. This multicenter observational study collects detailed information on patients treated with NST for node-positive breast cancer. It gathers data about the cancer, staging methods before and after NST, and treatment details from medical records. Patients complete questionnaires about their quality of life at diagnosis, and then 1 and 5 years later. The study database is maintained by the Netherlands Cancer Registry and aims to inform future treatment guidelines. Participants provide information through patient-reported outcome measures and undergo regular clinical follow-up to monitor disease-free survival, breast cancer-specific survival, overall survival, and rates of cancer recurrence in the lymph nodes over five years. Quality of life is assessed using several validated tools at baseline and during follow-up. The study results will help balance treatment decisions between less and more invasive options and support shared decision making for women with this breast cancer type.

Age: 18Years +FEMALE
35 locations